Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis
Authors
Keywords
Meta-analysis, Electric countershock, Stroke, Anticoagulants, Cardioversion, Transesophageal echocardiography
Journal
Clinical Research in Cardiology
Volume 104, Issue 7, Pages 582-590
Publisher
Springer Nature
Online
2015-02-02
DOI
10.1007/s00392-015-0821-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of Short-Term Use of Dabigatran or Rivaroxaban for Direct-Current Cardioversion in Patients With Atrial Fibrillation and Atrial Flutter
- (2014) Ajay Yadlapati et al. AMERICAN JOURNAL OF CARDIOLOGY
- Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
- (2014) Daniel Caldeira et al. HEART
- The risk of infection with new oral anticoagulants: A meta-analysis
- (2014) Daniel Caldeira et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria
- (2014) Andreas Clemens et al. PLoS One
- Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
- (2014) Torben Larsen et al. THROMBOSIS AND HAEMOSTASIS
- Drug adherence in patients taking oral anticoagulation therapy
- (2013) Sebastian Ewen et al. Clinical Research in Cardiology
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
- (2013) Jonathan P. Piccini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
- (2013) Greg Flaker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- General mechanisms of coagulation and targets of anticoagulants (Section I)
- (2013) Steen Husted et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
- (2011) Rangadham Nagarakanti et al. CIRCULATION
- Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
- (2011) J. H. H. Deuling et al. Netherlands Heart Journal
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPACE
- Long-Term Quality of Life After Ablation of Atrial Fibrillation
- (2010) Anita Wokhlu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More